Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DABRAFENIB Cause Wrong technique in product usage process? 63 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 63 reports of Wrong technique in product usage process have been filed in association with DABRAFENIB (Tafinlar). This represents 0.3% of all adverse event reports for DABRAFENIB.

63
Reports of Wrong technique in product usage process with DABRAFENIB
0.3%
of all DABRAFENIB reports
9
Deaths
15
Hospitalizations

How Dangerous Is Wrong technique in product usage process From DABRAFENIB?

Of the 63 reports, 9 (14.3%) resulted in death, 15 (23.8%) required hospitalization, and 1 (1.6%) were considered life-threatening.

Is Wrong technique in product usage process Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DABRAFENIB. However, 63 reports have been filed with the FAERS database.

What Other Side Effects Does DABRAFENIB Cause?

Pyrexia (3,788) Death (2,740) Malignant neoplasm progression (1,667) Fatigue (1,328) Nausea (1,300) Chills (1,235) Rash (1,078) Vomiting (907) Diarrhoea (901) Headache (697)

What Other Drugs Cause Wrong technique in product usage process?

EVOLOCUMAB (21,664) ALBUTEROL (17,114) ADALIMUMAB (11,766) PEGFILGRASTIM (10,217) ETANERCEPT (9,835) ERENUMAB-AOOE (9,359) SACUBITRIL\VALSARTAN (8,022) LEUPROLIDE (5,062) FENTANYL (2,812) SEMAGLUTIDE (2,538)

Which DABRAFENIB Alternatives Have Lower Wrong technique in product usage process Risk?

DABRAFENIB vs DABRAFENIB\TRAMETINIB DABRAFENIB vs DACARBAZINE DABRAFENIB vs DACLATASVIR DABRAFENIB vs DACLIZUMAB DABRAFENIB vs DACOMITINIB

Related Pages

DABRAFENIB Full Profile All Wrong technique in product usage process Reports All Drugs Causing Wrong technique in product usage process DABRAFENIB Demographics